期刊文献+

扶正化瘀法调控脂联素对非酒精性脂肪性肝病脂质代谢的影响 被引量:4

Fuzheng Huayu Therapy on Lipoid Metabolism of Model Rats With Nonalcoholic Fatty Liver Through Regulation on Adiponectin Level
下载PDF
导出
摘要 目的:探讨活血化瘀药配伍扶正药对非酒精性脂肪肝脂质代谢的影响。方法:将60只Wister雄性大鼠分为正常组、高脂组、Re组、丹参酮ⅡA组、Re+丹参酮ⅡA组、对照组,予以高脂饲料喂养建立胰岛素抵抗模型,喂养2 w后进行药物干预,共给药4 w。观察各组动物体重增加量的变化,取血清检测甘油三酯、胆固醇、游离脂肪酸和脂联素浓度。结果:各组间大鼠体重增量比较,差异无统计学意义。与对照组比较,Re组、Re+丹参酮ⅡA组TG、CHOL含量降低,差异有统计学意义(P<0.05)。Re+丹参酮ⅡA组FFA、ADP水平接近正常组,优于其他组。结论:Re与丹参酮ⅡA联合使用,有改善IR模型大鼠脂质代谢紊乱的作用。 Objective:To observe effect of herbs for invigorating blood circulation and eliminating stasis combined with herbs for strengthening the body resistance on lipoid metabolism of model rats with nonalcoholic fatty liver. Methods:60 Wistar rats were randomly divided into normal group, high lipid group, Re group, tanshinone Ⅱ A group, Re combined with tanshinone Ⅱ A group, control group.In addition to rats in normal group,all rats in other groups were fed high-fat diet for 2 weeks to construct insulin resistance rat models.4 weeks after administration,addition of weight of rats and contents of serum TG, C HOL, FFA,APD were detected. Result:There were no significantly group differences in addition of weight of rats. Compared with control group, contents of TG, CHOL were decreased in Re group and Re combined with tanshinone Ⅱ A group (P〈0.05). Contents of FFA,ADP in Re combined with tanshinone Ⅱ A group were close to those of normal group, and superior to those of other groups. Conclusion : Ginsenside Re combined with tanshinone Ⅱ A could improve lipid metabolism disorder of insulin resistance model rats.
机构地区 上海中医药大学
出处 《山西中医学院学报》 2012年第3期35-37,共3页 Journal of Shanxi College of Traditional Chinese Medicine
基金 博士点建设基金项目(K120307)
关键词 非酒精性脂肪肝 胰岛素抵抗 人参皂苷RE 丹参酮ⅡA 脂联素 nonalcoholic fatty liver disease insulin resistance ginsenside Re tanshinone Ⅱ A adiponectin
  • 相关文献

参考文献11

二级参考文献68

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2徐罗玲,吴琦,王佰瑶,杨秀岑,伍莉萍.丹参酮对人中性粒细胞氧自由基释放的抑制效应[J].中国病理生理杂志,1994,10(6):635-638. 被引量:40
  • 3黄熙,臧益民.丹参酮ⅡA磺酸钠心血管药理[J].国外医学(中医中药分册),1995,17(1):9-12. 被引量:66
  • 4Jameson.Principles of Molecular Medicine NO[M].America:Humana Jpress,1998:167.
  • 5Scherer PE,Willians S,Fogliano M,et al.A novel serum protein similar to C1q,produced exclusively in adipocytes[J].J Biol Chem,1995,270(45):2646-2649.
  • 6Maeda K,Okubo K,Shimomura I,et al.cDNA cloning and expression of a novel adipose specific collagen 2 like factor,apM1 (AdiPose Most abundant Gene transcript 1)[J].Bi ochem Biophys Res Commun,1996,221(2):286-289.
  • 7Hu E,Liang P,Spiegelman BM.Adipo Q is a novel adipose specific gene dysregulated in obesity[J].J Biol Chem,1996,271(5):10697-10736.
  • 8Hara K,Boutin P,Mori Y,et al.Genetic variation in the gene encodingadiponectin is associated with an increased risk of type 2 diabetes in the Japanese population[J].Diabetes,2002,51 (2):536-540.
  • 9Stumvoll M,Tschritter O,Fritsche A,et al.Association and the T-G polymorphismin adiponectin (exon 2) with obesity and insulin sensitivity:interaction with family of type 2 diabetes[J].Diabetes,2002,51 (1):37-41.
  • 10Comuzzie AG,Funahashi T,Sonnenberg G,et al.The Genetic basis of plasma variation in adiponectin,a global endophenotype for obesity and the metabolic syndrome[J].J Clin Endocrinal Metab,2001,86(9):4321-4325.

共引文献210

同被引文献99

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部